Clinical update: intravenous iron for anaemia

被引:142
作者
Auerbach, Michael [1 ]
Ballard, Harold
Glaspy, John
机构
[1] Georgetown Univ, Sch Med, Baltimore, MD 21237 USA
[2] NYU, Sch Med, New York Harbor Healthcare Syst, Dept Vet Affairs, New York, NY USA
[3] Univ Calif Los Angeles, Sch Med, Los Angeles, CA USA
关键词
D O I
10.1016/S0140-6736(07)60689-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1502 / 1504
页数:3
相关论文
共 20 条
[1]   Erythropoietin for end-stage renal disease [J].
Adamson, JW ;
Eschbach, JW .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (09) :625-627
[2]   Anemia of inflammation: the cytokine-hepcidin link [J].
Andrews, NC .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (09) :1251-1253
[3]   Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: A multicenter, open-label, randomized trial [J].
Auerbach, M ;
Ballard, H ;
Trout, JR ;
McIlwain, M ;
Ackerman, A ;
Bahrain, H ;
Balan, S ;
Barker, L ;
Rana, J .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (07) :1301-1307
[4]   A randomized trial of three iron dextran infusion methods for anemia in EPO-treated dialysis patients [J].
Auerbach, M ;
Winchester, J ;
Wahab, A ;
Richards, K ;
McGinley, M ;
Hall, F ;
Anderson, J ;
Briefel, G .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 31 (01) :81-86
[5]   Value of methylprednisolone in prevention of the arthralgia-myalgia syndrome associated with the total dose infusion of iron dextran: A double blind randomized trial [J].
Auerbach, M ;
Chaudhry, M ;
Goldman, H ;
Ballard, H .
JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1998, 131 (03) :257-260
[6]  
AUERBACH M, 1988, J LAB CLIN MED, V111, P566
[7]   Intravenous iron sucrose: Establishing a safe dose [J].
Chandler, G ;
Harchowal, J ;
Macdougall, IC .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 38 (05) :988-991
[8]   Update on adverse drug events associated with parenteral iron [J].
Chertow, GM ;
Mason, PD ;
Vaage-Nilsen, O ;
Ahlmén, J .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 (02) :378-382
[9]   On the relative safety of parenteral iron formulations [J].
Chertow, GM ;
Mason, PD ;
Vaage-Nilsen, O ;
Ahlmén, J .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (06) :1571-1575
[10]   REDUCTION IN RECOMBINANT-HUMAN-ERYTHROPOIETIN DOSES BY THE USE OF CHRONIC INTRAVENOUS IRON SUPPLEMENTATION [J].
FISHBANE, S ;
FREI, GL ;
MAESAKA, J .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1995, 26 (01) :41-46